American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Check-Cap Ltd (MBAI)

$1.10 -5.98% NASDAQ: MBAI · 15-min delayed

Public · NASDAQ: MBAI
85 employees

Visit website Follow

$10.7MMarket cap

$4.1MNet income

85Employees

MBAINASDAQ

2015IPO

About Check-Cap Ltd

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · NASDAQ: MBAI
Employees: 85
IPO date: Mar 18, 2015
Industry: Medical Devices
Website: Visit site

Registry IDs

Ticker: MBAI Nasdaq
SEC CIK: 1610590
SIC: 3844 X-Ray Apparatus & Tubes & Related Irradiation Apparatus

Embed this company’s badge

Show Check-Cap Ltd’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/check-cap-ltd/"><img src="https://americancompanies.com/badge/check-cap-ltd.svg" alt="Check-Cap Ltd — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Check-Cap Ltd and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Net income: $4.1M
Total assets: $7.5M
Market cap: $10.7M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: MBAI

$1.10 -5.98%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.95 $3.16

52-week range

Market cap: $10.7M
Shares outstanding: 9.7M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Mar 18, 2015

Check-Cap Ltd (MBAI) Stock Price

Profitable — net income of $4.1M.
Trading 65% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Check-Cap Ltd.

Write a review

Newsroom

News about Check-Cap Ltd

Humanoid Global Announces MBody AI’s Advancements in Commercial Expansion and Proposed Business Combination with Check-Cap GlobeNewswire Inc. · 2026-07-14 · positive MBody AI Corp. Expands Fortune 500 Deployment, Advancing National Robotics Rollout Benzinga · 2026-03-26 · positive MBody AI and Check Cap Ltd. ($MBAI) Submit Nasdaq Listing Application for Merger Close Benzinga · 2026-02-24 · positive Check-Cap Advances MBody AI Merger with F-1 Filing and MBody AI Audited Financials Benzinga · 2026-02-02 · positive Check-Cap Clears Key Nasdaq Requirement, Advancing MBody AI Merger Toward Completion Benzinga · 2026-01-26 · positive

News & sentiment via Polygon.io

FAQ

Check-Cap Ltd: frequently asked questions

Is Check-Cap Ltd an American company?

Check-Cap Ltd is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Check-Cap Ltd publicly traded?

Yes — Check-Cap Ltd is a publicly traded company. Its stock trades under the ticker symbol MBAI on the NASDAQ.

What does Check-Cap Ltd do?

Check-Cap Ltd is an American Medical Devices company in the Health & Beauty sector.

Explore